Clinical trials
Phase 1 Lymphoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 9 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 7 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 33 |
| Recruiting | 17 |
| Completed | 17 |
| Not yet recruiting | 7 |
| Terminated | 3 |
| Withdrawn | 2 |
| Suspended | 2 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| iCell Gene Therapeutics | 4 |
| Beijing Doing Biomedical Co., Ltd. | 3 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 3 |
| Chinese PLA General Hospital | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| Shanghai Junshi Bioscience Co., Ltd. | 3 |
| Beijing Boren Hospital | 2 |
| Hebei Senlang Biotechnology Inc., Ltd. | 2 |
| Shanghai Henlius Biotech | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 83 |
| Leukemia | 14 |
| Recurrence | 14 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Hematologic Neoplasms | 4 |
| Lymphoma, B-Cell | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Multiple Myeloma | 4 |
| Neoplasms | 4 |
| Lymphoma, T-Cell | 3 |
Trials
Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.